Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

APEX Ventures

Founders Andreas Riegler Christoph Kanneberger Stefan Haubner

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 47
Average round size
info
The average size of a deal this fund participated in
$3M
Portfolio companies 29
Rounds per year 5.88
Lead investments 7
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.38
Key employees Soon
Stages of investment
Early Stage Venture
Seed

Areas of investment

  • Information Technology
  • Biotechnology
  • Software
  • Artificial Intelligence
  • Medical

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of APEX Ventures:
Typical Co-investors
APEX Ventures is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after APEX Ventures:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from Austria
Funds with similar focus located in Austria:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Senisca

Biotechnology
$5M18 Mar 2024 Exeter, England, United Kingdom

Zetta Genomics

Biotechnology
Life Science
Medical
$2M08 Feb 2024 Cambridge, Cambridgeshire, United Kingdom

sewts

$8M09 Aug 2023 Germany, Bavaria, Germany

Pockit Diagnostics

Health Care
$2M27 Jun 2023 Cambridge, England, United Kingdom

Zetta Genomics

Biotechnology
Life Science
Medical
$2M17 Apr 2023 Cambridge, Cambridgeshire, United Kingdom

Refined Laser Systems

Electronics
Manufacturing
$3M26 Jan 2023 Niedersachsen, Lower Saxony, Germany

OroraTech

Forestry
Image Recognition
Information Services
Software
$18M30 Nov 2022 Munich, Bavaria, Germany

CardiaTec Biosciences

Biotechnology
Life Science
$1M06 Jul 2022 Cambridge, Cambridgeshire, United Kingdom

OKAPI:Orbits

Satellite Communication
Space Travel
$6M13 Jun 2022 Brunswick, Lower Saxony, Germany
News
contextflow Raises €6.7M in Series A Funding

– contextflow from Vienna develops artificial intelligence for medical image analysis.
– A second closing included an additional €2M from new co-investor Peak Pride Management GmbH, HPH (Hans Peter Haselsteiner) Start-up Unit and current investor APEX Ventures with its “APEX Best in Class” fund. A first closing was led by B&C Innovation Investments GmbH (BCII) and included participation from new co-investor TTIP Beteiligungs GmbH and current investors APEX Ventures, Crista Galli Ventures, IST cube, Nina Capital and Novacapital.
– The new investment will be used to accelerate market entry in Europe and the US, including obtaining FDA clearance for contextflow SEARCH Lung CT, as well as extending its offerings to include new products and features covering a wider range of organs and modalities.

Mobius Labs nabs $6M to help more sectors tap into computer vision

– Mobius Labs, a Berlin-based computer vision training platform, raised €5.2m funding.
– The round was led by Ventech VC and joined by Atlantic Labs, APEX Ventures, Space Capital, Lunar Ventures plus some additional angel investors.
– The startup offers an SDK that lets the user create custom computer vision models fed with a little of their own training data — as an alternative to off-the-shelf tools which may not have the required specificity for a particular use-case.
– It also flags a ‘no code’ focus, saying its tech has been designed with a non-technical user in mind.
– Mobius Labs — which was founded back in 2018 — now has 30 customers using its tools for a range of use cases.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent APEX Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 47
Average round size 3M
Rounds per year 5.88
Peak activity year 2021
Lead investments 7
Follow on index 0.38
Group Appearance index 0.94

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Senisca

Biotechnology
$5M18 Mar 2024 Exeter, England, United Kingdom

Zetta Genomics

Biotechnology
Life Science
Medical
$2M08 Feb 2024 Cambridge, Cambridgeshire, United Kingdom

sewts

$8M09 Aug 2023 Germany, Bavaria, Germany

Pockit Diagnostics

Health Care
$2M27 Jun 2023 Cambridge, England, United Kingdom

Zetta Genomics

Biotechnology
Life Science
Medical
$2M17 Apr 2023 Cambridge, Cambridgeshire, United Kingdom

Refined Laser Systems

Electronics
Manufacturing
$3M26 Jan 2023 Niedersachsen, Lower Saxony, Germany

OroraTech

Forestry
Image Recognition
Information Services
Software
$18M30 Nov 2022 Munich, Bavaria, Germany

CardiaTec Biosciences

Biotechnology
Life Science
$1M06 Jul 2022 Cambridge, Cambridgeshire, United Kingdom

OKAPI:Orbits

Satellite Communication
Space Travel
$6M13 Jun 2022 Brunswick, Lower Saxony, Germany
Crunchbase icon

Content report

The following text will be sent to our editors: